Nanobiotix
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Nanobiotix
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
/ 
Frequently asked questions
To buy Nanobiotix stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Nanobiotix by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Nanobiotix is NANO:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Nanobiotix has its primary listing on Euronext Paris. You can trade Nanobiotix with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Nanobiotix is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Nanobiotix as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Nanobiotix.